<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000468784"><TermName>fluorothymidine F 18</TermName><TermPronunciation>(FLOOR-oh-THY-mih-DEEN…)</TermPronunciation><TermDefinition><DefinitionText>A radioactive substance being studied in the diagnosis of cancer. Fluorothymidine F 18 is injected into the blood and builds up in cells that are dividing, including cancer cells. The radiation that it gives off as it decays (breaks down) helps make clear pictures of tumors during positron emission tomography (PET) scans. It is a type of radiopharmaceutical. Also called 18F-FLT and 3’-deoxy-3’-(18F) fluorothymidine.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000716811" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;fluorothymidine F 18&quot;" language="en" id="_3"/><MediaLink ref="CDR0000716810" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;fluorotimidina F 18&quot;" language="es" id="_4"/><SpanishTermName>fluorotimidina F 18</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia radiactiva en  estudio para el diagnóstico de cáncer. La fluorotimidina F 18 se inyecta en la sangre y se acumula en las células que se multiplican, incluso las células cancerosas. La radiación que despide a medida que se deteriora (descompone) ayuda a lograr imágenes claras de los tumores durante las gammagrafías  por tomografía con emisión de positrones (TEP). Es un tipo de radiofármaco. También se llama 18F-FLT y 3’-deoxi-3’-(18F) fluorotimidina.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2006-10-14</DateFirstPublished><DateLastModified>2008-11-21</DateLastModified></GlossaryTerm>
